Invention Grant
US07988975B2 Modified HIV-1 group M cyclic gp41 peptides and their use in the detection of anti-HIV-1 antibodies
有权
修饰的HIV-1组M环gp41肽及其在检测抗HIV-1抗体中的应用
- Patent Title: Modified HIV-1 group M cyclic gp41 peptides and their use in the detection of anti-HIV-1 antibodies
- Patent Title (中): 修饰的HIV-1组M环gp41肽及其在检测抗HIV-1抗体中的应用
-
Application No.: US11659491Application Date: 2005-07-27
-
Publication No.: US07988975B2Publication Date: 2011-08-02
- Inventor: Stéphane Gadelle , Francois Rieunier
- Applicant: Stéphane Gadelle , Francois Rieunier
- Applicant Address: FR Marnes la Coquette
- Assignee: Bio-Rad Pasteur
- Current Assignee: Bio-Rad Pasteur
- Current Assignee Address: FR Marnes la Coquette
- Agency: Jacobson Holman PLLC
- Priority: FR0408733 20040806
- International Application: PCT/FR2005/001969 WO 20050727
- International Announcement: WO2006/024752 WO 20060309
- Main IPC: A61K39/21
- IPC: A61K39/21 ; A61K38/00 ; C12Q1/70
Abstract:
The invention involves a synthetic peptide derived from HIV-1 virus gp41 having sequence where X615 is F or G, a method of preparing the synthetic peptide, a composition and a kit containing the synthetic peptide, and use of the synthetic peptide in immunoassays for the detection of infections caused by HIV-1 viruses.
Public/Granted literature
- US20090263785A1 Modified HIV-1 Peptides and Use Thereof in the Detection of Anit-HIV Antibodies Public/Granted day:2009-10-22
Information query
